Abstract
Gliomas account for approximately 80% of primary malignant brain tumors in adults. The highly infiltrating and aggressive glioblastoma subtype (grade IV) corresponds to an average patient survival around 15 months after diagnosis. Advances in knowledge of new therapeutic options have not yet significantly improved the survival of these patients, who are currently treated using surgical re…